- Market cap
- Revenue
- Net income
- Cash on hand
- Gross margin
- Net margin
- EPS
- P/E ratio
In 1956, Sorin Biomedica was founded by Italy's two largest industrial groups at that time: Fiat and Montedison (now under Edison ). The name 'Sorin' is an acronym for Società Ricerche Impianti Nucleari (Company for Nuclear Plant Research). Later the company became known as Sorin Group.
In 1987, Cyberonics, Inc. was founded in Houston, United States.
In March 2015, the two companies announced they would be merging in a $2.7B transaction. The transaction closed and the company began trading under the new stock symbol on Oct. 19. 2015. In December 2017, LivaNova announced it would acquire Imthera Medical for approximately $224M.
In 2018, LivaNova sold its cardiac rhythm management business unit to MicroPort for $190M.
In 2020, LivaNova announced the sale of its heart valve (HV) business, which became Corcym.
In May 2022, Livanova announced the acquisition of Pittsburgh based biotechnology company ALung Technologies Inc. LivaNova PLC will acquire the 97% interest in privately held ALung that it doesn’t currently own for the $10 million deal.
In April 2023, CEO Damien McDonald resigned.
On March 1, 2024, Vladimir Makatsaria was appointed LivaNova's new CEO and Board Director.